Driving-related risks and impact of methylphenidate treatment on driving in adults with attention-deficit/hyperactivity disorder (ADHD)

被引:0
|
作者
E. Sobanski
D. Sabljic
B. Alm
G. Skopp
N. Kettler
R. Mattern
P. Strohbeck-Kühner
机构
[1] Central Institute of Mental Health,Department of Psychiatry and Psychotherapy
[2] Ruprechts-Karl-University of Heidelberg,Institutes of Traffic and Legal Medicine
来源
Journal of Neural Transmission | 2008年 / 115卷
关键词
Keywords: Driving outcome; attention-deficit/hyperactivity disorder; methylphenidate; adults;
D O I
暂无
中图分类号
学科分类号
摘要
This study assesses driving behaviour and history of driving outcomes through a semi-structured interview in 27 clinically referred German adults with ADHD and 27 age-, gender- and education-matched non-ADHD controls. In nineteen of the ADHD-subjects a test battery of driving-related cognitive measures was performed (ART 2020) and re-assessed after at least six weeks of treatment with methylphenidate (n = 9) or after a six-week medication free period (n = 10).
引用
收藏
页码:347 / 356
页数:9
相关论文
共 50 条
  • [11] Distracted Driving With Attention-Deficit/Hyperactivity Disorder
    Madaan, Vishal
    Cox, Daniel J.
    JAMA PSYCHIATRY, 2017, 74 (06) : 603 - 604
  • [13] Diagnosis and Treatment of Adults with Attention-Deficit/Hyperactivity Disorder (ADHD)
    Haskell, Brittany
    Carter-Orbke, Mary
    Vick, Rose
    Madden, Brandee
    Smith, Letizia
    JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2024, 20 (10):
  • [14] Methylphenidate significantly improves driving performance of adults with attention-deficit hyperactivity disorder: a randomized crossover trial
    Verster, Joris C.
    Bekker, Evelijne M.
    de Roos, Marlise
    Minova, Anita
    Eijken, Erik Je
    Kooij, J. J. Sandra
    Buitelaar, Jan K.
    Kenemans, J. Leon
    Verbaten, Marinus N.
    Olivier, Berend
    Volkerts, Edmund R.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2008, 22 (03) : 230 - 237
  • [15] The effect of attention-deficit/hyperactivity disorder (ADHD) on driving behavior and risk perception
    Lidestam, B.
    Selander, H.
    Vaa, T.
    Thorslund, B.
    TRAFFIC INJURY PREVENTION, 2021, 22 (02) : 108 - 113
  • [16] Impact of methylphenidate delivery profiles on driving performance of adolescents with attention-deficit/hyperactivity disorder: A pilot study
    Cox, DJ
    Merkel, RL
    Penberthy, JK
    Kovatchev, B
    Hankin, CS
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2004, 43 (03): : 269 - 275
  • [17] METHYLPHENIDATE USE IN IMPROVING AUTO DRIVING PERFORMANCE IN ADOLESCENTS WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER
    SENTER, S
    BUTTROSS, S
    RAGGIO, D
    CLINICAL RESEARCH, 1993, 41 (04): : A745 - A745
  • [18] ALERTNESS AND DRIVING PERFORMANCE IN ADULTS AFFECTED BY ATTENTION DEFICIT DISORDER/HYPERACTIVITY (ADHD)
    Philip, P.
    Bioulac, S.
    Capelli, A.
    Claret, A.
    Gauduchau, M.
    Sagaspe, P.
    Taillard, J.
    Reneric, J.
    Bouvard, M.
    SLEEP, 2012, 35 : A341 - A341
  • [19] Effect of long-acting OROS methylphenidate on routine driving in young adults with attention-deficit/hyperactivity disorder
    Cox, Daniel J.
    Mikami, Amori Yee
    Cox, Brian S.
    Coleman, Margaret Taylor
    Mahmood, Aamir
    Sood, Ajay
    Moore, Melissa
    Burket, Roger
    Merkel, R. Lawrence
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2008, 162 (08): : 793 - 794
  • [20] Quantifying the Benefits and Risks of Methylphenidate as Treatment for Childhood Attention-Deficit/Hyperactivity Disorder
    Shaw, Philip
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (18): : 1953 - 1955